Ajanta Pharma secures final approval for 3 ANDAs
From USFDA
Ajanta Pharma has received final approval for its 3 ANDAs (Abbreviated New Drug Application) by US FDA (United States Food and Drug Administration) -
Montelukast Tablets, 10mg
Montelukast Sodium Chewable Tablets, 4mg & 5mg and
Montelukast oral granules.
Powered by Capital Market - Live News